← back to search

Wei He

Boston Children's Hospital · US
Area of research
Hepatology · Surgery
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Cholangiocarcinoma and Gallbladder Cancer Studies, Liver Disease Diagnosis and Treatment, and Multiple Myeloma Research and Treatments.
h-index
34
citations
4,597
works
221
NIH funding
primary concept
email

Recent publications

Targeting PRMT3 impairs methylation and oligomerization of HSP60 to boost anti-tumor immunity by activating cGAS/STING signaling
Nature Communications 2024cited by 40position: middledoi
Giant Negative Photoresponse in van der Waals Graphene/AgBiP<sub>2</sub>Se<sub>6</sub>/Graphene Trilayer Heterostructures
Advanced Materials 2024cited by 38position: firstdoi
Higher dietary live microbe intake is associated with a lower risk of sarcopenia
Clinical Nutrition 2024cited by 34position: middledoi
Watch-and-wait strategy vs. resection in patients with radiologic complete response after conversion therapy for initially unresectable hepatocellular carcinoma: a propensity score-matching comparative study
International Journal of Surgery 2024cited by 33position: middledoi
Atezolizumab and bevacizumab plus transarterial chemoembolization and hepatic arterial infusion chemotherapy for patients with high tumor burden unresectable hepatocellular carcinoma: A multi-center cohort study
International Immunopharmacology 2024cited by 19position: middledoi
Early recurrence of hepatocellular carcinoma in patients after ablation and resection: A propensity score analysis.
2024cited by 3position: contributordoi
Characteristics and patient-reported outcomes of long-term cancer survivors after apatinib-based therapy: an online survey
BMC Cancer 2024cited by 1position: middledoi
PRMT3-mediated arginine methylation of IGF2BP1 promotes oxaliplatin resistance in liver cancer
Nature Communications 2023cited by 81position: middledoi
Record‐High Work‐Function p‐Type CuBiP <sub>2</sub> Se <sub>6</sub> Atomic Layers for High‐Photoresponse van der Waals Vertical Heterostructure Phototransistor
Advanced Materials 2023cited by 29position: firstdoi
Unique genomic characteristics underlie the infectivity of divergent Cryptosporidium hominis subtypes to animals
Research Square 2023cited by 3position: middledoi
Editorial: is microwave ablation an alternative to liver resection for hepatocellular carcinoma?
2023cited by 0position: contributordoi
S100A9 Derived from Chemoembolization‐Induced Hypoxia Governs Mitochondrial Function in Hepatocellular Carcinoma Progression
Advanced Science 2022cited by 72position: middledoi
Sequential treatment of severe airway stenosis caused by esophageal cancer by using airway stent implantation and arterial infusion chemotherapy
Scientific Reports 2022cited by 2position: middledoi
More Liver Metastases Detected Intraoperatively Indicates Worse Prognosis for Colorectal Liver Metastases Patients after Resection Combined with Microwave Ablation.
2022cited by 2position: contributordoi
Additional file 1 of Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma
Figshare 2022cited by 0position: middledoi
Conversion to Resectability Using Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma
Annals of Surgery Open 2021cited by 73position: middledoi
Development of PI3K inhibitors: Advances in clinical trials and new strategies (Review)
Pharmacological Research 2021cited by 69position: middledoi
Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma
Journal of Experimental & Clinical Cancer Research 2021cited by 58position: middledoi
Mitochondria-targeted cyclometalated rhodium(<scp>iii</scp>) complexes: synthesis, characterization and anticancer research
Dalton Transactions 2021cited by 32position: middledoi
Comprehensive Analysis to Identify the Encoded Gens of Sodium Channels as a Prognostic Biomarker in Hepatocellular Carcinoma.
2021cited by 4position: contributordoi
Anterolateral Necrotic Lesion Serves as an Early Warning Sign of Developing Collapse in Osteonecrosis of the Femoral Head
Research Square 2021cited by 1position: lastdoi
Additional file 1 of Elafin promotes tumour metastasis and attenuates the anti-metastatic effects of erlotinib via binding to EGFR in hepatocellular carcinoma
Figshare 2021cited by 0position: middledoi
Dysregulated Sp1/miR-130b-3p/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma
Theranostics 2020cited by 90position: middledoi
Microwave ablation <i>versus</i> resection for hepatocellular carcinoma within the Milan criteria: a propensity-score analysis.
2019cited by 26position: contributordoi
Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation.
2019cited by 22position: contributordoi
Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis
Alimentary Pharmacology & Therapeutics 2018cited by 122position: middledoi
Nomogram to Predict Survival of Patients With Recurrence of Hepatocellular Carcinoma After Surgery
Clinical Gastroenterology and Hepatology 2017cited by 74position: firstdoi
Mutual Regulation of MiR-199a-5p and HIF-1α Modulates the Warburg Effect in Hepatocellular Carcinoma
Journal of Cancer 2017cited by 46position: middledoi
Identification and characterization of human UDP-glucuronosyltransferases responsible for the in-vitro glucuronidation of arctigenin
Journal of Pharmacy and Pharmacology 2015cited by 14position: middledoi
NF-κB–mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia
Journal of Clinical Investigation 2013cited by 353position: firstdoi

Grants

CAREER: Immunologically Responsive Therapeutic Biomateirals to Modulate Wound Healing in the Nervous Systems: An Integrated Research and Education Plan
NSF1055208$400,0752011–2017PIRePORTER
Surface Science and Engineering Towards Bioactive Bulk Metallic Glasses
NSF1100080$296,5362011–2016PIRePORTER

Frequent collaborators

Yunfei Yuan · Sun Yat-sen University13 papers (2017–2024)Jiliang Qiu · Sun Yat-sen University12 papers (2017–2024)Dinglan Zuo · Sun Yat-sen University9 papers (2017–2024)Yunxing Shi · Sun Yat-sen University9 papers (2020–2024)Chenwei Wang · Baylor College of Medicine9 papers (2018–2024)Yuanping Zhang · Institute of Coal Chemistry8 papers (2017–2022)Zhiwen Yang · Tongji University7 papers (2018–2023)Binkui Li · Sun Yat-sen University7 papers (2017–2024)Wenwu Liu · Shenyang Pharmaceutical University7 papers (2017–2022)Yadi Liao · Northeast Forestry University6 papers (2020–2023)Yun-Fei Yuan · Sun Yat-sen University5 papers (2019–2023)Yuxiong Qiu · Sun Yat-sen University5 papers (2020–2024)Binkui Li · Sun Yat-sen University4 papers (2021–2024)Yichuan Yuan · Central University of Finance and Economics4 papers (2021–2024)Ruhai Zou · Sun Yat-sen University4 papers (2017–2024)Yun Zheng · Zhejiang Chinese Medical University4 papers (2017–2024)Yongjin Wang · Nanjing University of Posts and Telecommunications4 papers (2017–2021)Yichuan Yuan · Sun Yat-sen University3 papers (2020–2023) · 3 papers (2019–2023)Yi Niu · Ministry of Education of the People's Republic of China3 papers (2022–2024)